Effect of activin A on tubulointerstitial fibrosis in diabetic nephropathy

Nephrology

Volumn 14, Issue 3, 2009, Pages 311-320

  Ren, Xiao Jun ^a   Guan, Guang Ju ^a   Liu, Gang ^a   Zhang, Taoyan ^a   Liu, Gao Hong ^b  

^a SHANDONG UNIVERSITY   (China)

^b People Hospital of Shanxi Province   (China)

Author keywords

Activin A; Diabetic nephropathy; Follistatin; Renal fibrosis; Smad protein

Indexed keywords

ACTIVIN A; ALBUMIN; FIBRONECTIN; FOLLISTATIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY MASS; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; URINARY EXCRETION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FIBRONECTINS; FIBROSIS; FOLLISTATIN; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; KIDNEY TUBULES; MALE; RATS; RATS, WISTAR; SMAD2 PROTEIN; SMAD3 PROTEIN;

EID: 65349160349     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01059.x     Document Type: Article

References (26)

1. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine 2004 25 : 971 1010.
2. Thomas MC, Burns WC, Cooper ME. Tubular changes in early diabetic nephropathy. Adv. Chronic Kidney Dis. 2005 12 : 177 86.
3. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 2003 14 : 1358 73.
4. Peng C. The TGF-beta superfamily and its roles in the human ovary and placenta. J. Obstet. Gynaecol. Can. 2003 25 : 834 44.
5. Gilbert RE, Cox A, Wu LL et al. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition. Diabetes 1998 47 : 414 22.
6. Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int. 2007 71 : 846 54.
7. Fraser D, Brunskill N, Ito T, Phillips A. Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-beta 1 synthesis via an autocrine PDGF loop. Am. J. Pathol. 2003 163 : 2565 74.
8. Xiang G, Schinzel R, Simm A et al. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol. Dial. Transplant. 2001 16 : 1562 9.
9. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 2001 12 : 2392 9.
10. Ling N, Ying SY, Ueno N et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986 321 : 779 82.
11. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: From endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 2002 227 : 724 52.
12. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic inflammation. Mol. Cell. Endocrinol. 2004 225 : 119 25.
13. Phillips DJ. Activins, inhibins and follistatins in the large domestic species. Domest. Anim. Endocrinol. 2005 28 : 1 16.
14. Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S. Activins and inhibins and their signaling. Ann. N.Y. Acad. Sci. 2004 1038 : 142 7.
15. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. J. Biol. Chem. 1997 272 : 13835 42.
16. Yamashita S, Maeshima A, Kojima I, Nojima Y. Activin A is a potent activator of renal interstitial fibroblasts. J. Am. Soc. Nephrol. 2004 15 : 91 101.
17. Maeshima A, Nojima Y, Kojima I. The role of the activin-follistatin system in the developmental and regeneration processes of the kidney. Cytokine Growth Factor Rev. 2001 12 : 289 98.
18. Kojima I, Maeshima A, Zhang YQ. Role of the activin-follistatin system in the morphogenesis and regeneration of the renal tubules. Mol. Cell. Endocrinol. 2001 180 : 179 82.
19. Ball EM, Risbridger GP. Activins as regulators of branching morphogenesis. Dev. Biol. 2001 238 : 1 12.
20. Maeshima A, Zhang YQ, Nojima Y, Naruse T, Kojima I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J. Am. Soc. Nephrol. 2001 12 : 1685 95.
21. Munz B, Smola H, Engelhardt F et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999 18 : 5205 15.
22. Date M, Matsuzaki K, Matsushita M, Tahashi Y, Sakitani K, Inoue K. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J. Hepatol. 2000 32 : 251 60.
23. Wada W, Kuwano H, Hasegawa Y, Kojima I. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 2004 145 : 2753 9.
24. Ohga E, Matsuse T, Teramoto S et al. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem. Biophys. Res. Commun. 1996 228 : 391 6.
25. Abe Y, Minegishi T, Leung PC. Activin receptor signalling. Growth Factors 2004 22 : 105 10.
26. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997 390 : 465 71.